临床肿瘤学杂志

• 综述与讲座 • 上一篇    下一篇

microRNA-128: 肿瘤治疗新靶点

曹建刚,李赫宁,陈临溪   

  1. 421001 湖南衡阳 南华大学药物药理研究所
  • 收稿日期:2014-03-21 修回日期:2014-06-15 出版日期:2014-09-30 发布日期:2014-09-30
  • 通讯作者: 陈临溪

MicroRNA-128: A new target for oncotherapy

CAO Jiangang, LI Hening, CHEN Linxi.

  

  1. Institute of Pharmacy and Pharmacology, University of South China, Hengyang 421001, China
  • Received:2014-03-21 Revised:2014-06-15 Online:2014-09-30 Published:2014-09-30
  • Contact: CHEN Linxi

摘要:

微小RNA(miRNA)是体内一类长度为21~25个核苷酸的内源性非编码单链RNA,其主要通过完全或不完全互补结合至靶基因的3’非编码区而调控靶基因的表达。miRNA有多种类型,其中miR-128在多种疾病和正常组织中均不同程度的表达,具有广泛的调节作用。研究发现miR-128参与了神经胶质瘤、白血病、胃癌、肺癌及乳腺癌的发生过程,对细胞的分化、增殖、迁移和凋亡有重要作用。本文就miR-128在肿瘤中的研究进行详细阐述,以期为肿瘤的治疗提供新的靶点。

Abstract:

MicroRNA (miRNA) is a kind of small endogenous non-coding single RNA containing 21-25 nucleotides, which regulates the expression of target genes through complementary binding to the 3’ untranslated region completely or incompletely. MiR-128, one of the subtypes of miRNA, expresses differently in a variety of diseases and normal tissues and plays an enormous role. Studies found that miR-128 played fundamental roles in various aspects of cellular function including differentiation, proliferation,migration and apoptosis in the development of several kinds of tumors including glioma, leukemia, stomach cancer, lung cancer and breast cancer. In this review, we will articulate the relationship between miR-128 and cancers, hoping to provide a new target for the treatment of tumor.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!